Lanticse, Saturnino A.
HRN: 12-17-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/29/2022
12/06/2022
TOPICAL
Apply Thinly
BID
Dm Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes